Meridian Bioscience Reports Second Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Meridian Bioscience Reports Second Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance

Meridian Bioscience (VIVO) Reports In-Line Q2 EPS

April 28, 2016 7:48 AM EDT

Meridian Bioscience (NASDAQ: VIVO) reported Q2 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $51.3 million versus the consensus estimate of $52.1 million.

For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.

... More